Vránová Z, Janota M, Málek P, Vrána M
Cor Vasa. 1976;18(1):77-9.
Premature ventricular contractions are relatively often encountered in patients after surgical treatment of ischaemic heart disease. Mercurascan (MSC), given at 0.05 mg/kg of body weight, favourably affected both the incidence and duration of arrhythmia. Unlike other antiarrhythmics, MSC did not affect the heart rate nor blood pressure. Postoperative treatment of ventricular arrhythmia with MSC is a promising procedure and merits further clinical and experimental investigation.
缺血性心脏病手术治疗后的患者相对经常出现室性早搏。按0.05毫克/千克体重给予Mercurascan(MSC),对心律失常的发生率和持续时间均有有利影响。与其他抗心律失常药物不同,MSC不影响心率和血压。用MSC对室性心律失常进行术后治疗是一种有前景的方法,值得进一步进行临床和实验研究。